vs

Side-by-side financial comparison of CME Group (CME) and SONOCO PRODUCTS CO (SON). Click either name above to swap in a different company.

CME Group is the larger business by last-quarter revenue ($1.9B vs $1.7B, roughly 1.1× SONOCO PRODUCTS CO). SONOCO PRODUCTS CO runs the higher net margin — 4.1% vs 0.1%, a 4.0% gap on every dollar of revenue. On growth, CME Group posted the faster year-over-year revenue change (14.5% vs -1.9%). Over the past eight quarters, CME Group's revenue compounded faster (10.8% CAGR vs 1.2%).

CME Group Inc. is an American financial services company based in Chicago, Illinois. It operates financial derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company owns 27% of S&P Dow Jones Indices. It is the world's largest operator of financial derivatives exchanges. Its exchanges are platforms for trading in agricultural products, currencies, energy, i...

Sonoco Products Company is an American provider of diversified consumer packaging, industrial products, protective packaging, and packaging supply chain services and the world's largest producer of composite cans, tubes, and cores. The company was founded in 1889 as Southern Novelty Company with annualized net sales of approximately $7.3 billion. Sonoco has 19,900 employees in more than 335 operations in 33 countries, serving more than 85 nations. The company is headquartered in Hartsville, S...

CME vs SON — Head-to-Head

Bigger by revenue
CME
CME
1.1× larger
CME
$1.9B
$1.7B
SON
Growing faster (revenue YoY)
CME
CME
+16.4% gap
CME
14.5%
-1.9%
SON
Higher net margin
SON
SON
4.0% more per $
SON
4.1%
0.1%
CME
Faster 2-yr revenue CAGR
CME
CME
Annualised
CME
10.8%
1.2%
SON

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CME
CME
SON
SON
Revenue
$1.9B
$1.7B
Net Profit
$1.2M
$68.0M
Gross Margin
20.6%
Operating Margin
0.1%
7.6%
Net Margin
0.1%
4.1%
Revenue YoY
14.5%
-1.9%
Net Profit YoY
20.7%
24.1%
EPS (diluted)
$0.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CME
CME
SON
SON
Q1 26
$1.9B
$1.7B
Q4 25
$1.6B
$1.8B
Q3 25
$1.5B
$2.1B
Q2 25
$1.7B
$1.9B
Q1 25
$1.6B
$1.7B
Q4 24
$1.5B
Q3 24
$1.6B
$1.7B
Q2 24
$1.5B
$1.6B
Net Profit
CME
CME
SON
SON
Q1 26
$1.2M
$68.0M
Q4 25
$1.2B
$332.2M
Q3 25
$908.0M
$122.9M
Q2 25
$1.0B
$493.4M
Q1 25
$956.2M
$54.4M
Q4 24
$874.6M
Q3 24
$912.8M
$50.9M
Q2 24
$883.2M
$90.8M
Gross Margin
CME
CME
SON
SON
Q1 26
20.6%
Q4 25
19.6%
Q3 25
21.9%
Q2 25
21.3%
Q1 25
20.7%
Q4 24
Q3 24
21.4%
Q2 24
22.0%
Operating Margin
CME
CME
SON
SON
Q1 26
0.1%
7.6%
Q4 25
61.8%
29.4%
Q3 25
63.3%
9.1%
Q2 25
66.7%
9.2%
Q1 25
67.5%
7.4%
Q4 24
62.1%
Q3 24
64.6%
7.6%
Q2 24
65.3%
8.6%
Net Margin
CME
CME
SON
SON
Q1 26
0.1%
4.1%
Q4 25
71.7%
18.8%
Q3 25
59.1%
5.8%
Q2 25
60.6%
25.8%
Q1 25
58.2%
3.2%
Q4 24
57.3%
Q3 24
57.6%
3.0%
Q2 24
57.6%
5.6%
EPS (diluted)
CME
CME
SON
SON
Q1 26
$0.68
Q4 25
$3.24
$3.33
Q3 25
$2.49
$1.23
Q2 25
$2.81
$4.96
Q1 25
$2.62
$0.55
Q4 24
$2.40
Q3 24
$2.50
$0.51
Q2 24
$2.42
$0.92

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CME
CME
SON
SON
Cash + ST InvestmentsLiquidity on hand
$2.4B
$224.5M
Total DebtLower is stronger
$3.4B
$3.5B
Stockholders' EquityBook value
$3.6B
Total Assets
$202.0B
$11.1B
Debt / EquityLower = less leverage
0.97×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CME
CME
SON
SON
Q1 26
$2.4B
$224.5M
Q4 25
$4.5B
$378.4M
Q3 25
$2.6B
$244.9M
Q2 25
$2.1B
$329.8M
Q1 25
$1.5B
$181.8M
Q4 24
$3.0B
Q3 24
$2.4B
$1.9B
Q2 24
$1.9B
$140.2M
Total Debt
CME
CME
SON
SON
Q1 26
$3.4B
$3.5B
Q4 25
$3.8B
Q3 25
$3.8B
Q2 25
$5.0B
Q1 25
$5.0B
Q4 24
Q3 24
$4.3B
Q2 24
$2.5B
Stockholders' Equity
CME
CME
SON
SON
Q1 26
$3.6B
Q4 25
$28.7B
$3.6B
Q3 25
$28.2B
$3.3B
Q2 25
$27.7B
$3.2B
Q1 25
$27.0B
$2.4B
Q4 24
$26.5B
Q3 24
$28.2B
$2.5B
Q2 24
$27.6B
$2.4B
Total Assets
CME
CME
SON
SON
Q1 26
$202.0B
$11.1B
Q4 25
$198.4B
$11.2B
Q3 25
$187.1B
$11.7B
Q2 25
$179.9B
$12.0B
Q1 25
$157.8B
$12.7B
Q4 24
$137.4B
Q3 24
$137.8B
$9.0B
Q2 24
$123.4B
$7.2B
Debt / Equity
CME
CME
SON
SON
Q1 26
0.97×
Q4 25
1.05×
Q3 25
1.15×
Q2 25
1.54×
Q1 25
2.03×
Q4 24
Q3 24
1.74×
Q2 24
1.04×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CME
CME
SON
SON
Operating Cash FlowLast quarter
Free Cash FlowOCF − Capex
$-428.3B
FCF MarginFCF / Revenue
-25554.2%
Capex IntensityCapex / Revenue
3601.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-427.6B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CME
CME
SON
SON
Q1 26
Q4 25
$1.1B
$412.9M
Q3 25
$968.1M
$291.5M
Q2 25
$1.1B
$193.4M
Q1 25
$1.1B
$-208.1M
Q4 24
$1.0B
Q3 24
$1.0B
$162.1M
Q2 24
$776.9M
$109.3M
Free Cash Flow
CME
CME
SON
SON
Q1 26
$-428.3B
Q4 25
$1.1B
$322.3M
Q3 25
$949.7M
$225.6M
Q2 25
$1.0B
$98.6M
Q1 25
$1.1B
$-300.8M
Q4 24
$991.7M
Q3 24
$973.2M
$70.5M
Q2 24
$758.7M
$16.0M
FCF Margin
CME
CME
SON
SON
Q1 26
-25554.2%
Q4 25
66.8%
18.2%
Q3 25
61.8%
10.6%
Q2 25
61.5%
5.2%
Q1 25
67.1%
-17.6%
Q4 24
65.0%
Q3 24
61.4%
4.2%
Q2 24
49.5%
1.0%
Capex Intensity
CME
CME
SON
SON
Q1 26
3601.4%
Q4 25
2.0%
5.1%
Q3 25
1.2%
3.1%
Q2 25
1.1%
5.0%
Q1 25
0.9%
5.4%
Q4 24
1.7%
Q3 24
1.9%
5.5%
Q2 24
1.2%
5.7%
Cash Conversion
CME
CME
SON
SON
Q1 26
Q4 25
0.96×
1.24×
Q3 25
1.07×
2.37×
Q2 25
1.03×
0.39×
Q1 25
1.17×
-3.82×
Q4 24
1.16×
Q3 24
1.10×
3.18×
Q2 24
0.88×
1.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CME
CME

Segment breakdown not available.

SON
SON

Consumer Packaging$1.1B65%
Industrial Paper Packaging$579.4M35%
All Other$55.1M3%

Related Comparisons